QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
January 19 2022 - 8:20AM
Business Wire
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA)
announced today that it plans to release its report on results for
the fourth quarter and full-year results of 2021 on Tuesday,
February 8, at approximately 16:05 Eastern Standard Time
(EST) / 22:05 Central European Time (CET).
A conference call is scheduled for Wednesday, February 9 at
15:00 Frankfurt time / 14:00 London time / 09:00 New York
time. It will be hosted by Thierry Bernard, Chief Executive
Officer, and Roland Sackers, Chief Financial Officer.
Conference call and webcast details
Please use the following link to have the conference call you:
Connect Me. This „click to join function” will be
available 15 minutes before the call starts. Please enter your
name, company and phone number, and you will be connected to the
call.
Alternatively, you may listen to the call by dialling: +1 929
477 0402 (U.S.), +44 (0)330 336 9125 (UK), +49 (0) 69 2222 25574
(Germany)
To avoid waiting time, please join the event conference 5-10
minutes prior to the start time. Conference ID:
5585677
The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1523538&tp_key=66be96605b
A conference call replay will be available by using the
following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1523538&tp_key=66be96605b
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample to Insight solutions that enable
customers to gain valuable molecular insights from samples
containing the building blocks of life. Our sample technologies
isolate and process DNA, RNA and proteins from blood, tissue and
other materials. Assay technologies make these biomolecules visible
and ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights. Automation
solutions tie these together in seamless and cost-effective
workflows. QIAGEN provides solutions to more than 500,000 customers
around the world in Molecular Diagnostics (human healthcare),
Applied Testing (primarily forensics), Pharma (pharma and biotech
companies) and Academia (life sciences research). As of December
31, 2021, QIAGEN employed more than 6,000 people in over 35
locations worldwide. Further information can be found at
http://www.qiagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220119005616/en/
John Gilardi Vice President, Head of Corporate Communications
and Investor Relations +49 2103 29 11711 +1 240 686 2222 Email:
ir@qiagen.com Phoebe Loh Senior Director Investor Relations +49
2103 29 11457 Email: ir@qiagen.com
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Aug 2023 to Aug 2024